The Exchange has received the following disclosure under Regulation 7(1A) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 1997: | Name of the Target company | Kilitch Drugs India Ltd | | Name of the acquirer and PACs with the acquirer | Paresh P Mehta | | Details | Number | % | | a) Shares / VR* before acquisition under consideration | 940,968 | 7.13% | | b) Shares / VR* acquired / (sold) | (95,000) | (0.72%) | | c) Shares / VR* after acquisition / sale | 845,968 | 6.41% | | Mode of acquisition / sale | Open Market | | Date of acquisition / sale of shares | Nov 07, 2007 | *VR - Voting Rights |